NORDEN GROUP LLC

Position in NVO — Novo Nordisk A S

CIK 1990699 PROVO, UT

Position in NVO

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,859,544

+$292,083 QoQ

Shares Held

38,789

-9.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#396

of 1,348 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORDEN GROUP LLC holds $53,447,474 across 12 Drug Manufacturers - General names. NVO ranks #8 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	223,889	$12,900,484
2	LLY	ELI LILLY & Co	7,327	$8,788,224
3	JNJ	Johnson & Johnson	34,402	$8,737,075
4	MRK	Merck & Co., Inc.	45,186	$5,806,401
5	ABBV	AbbVie Inc.	19,879	$5,002,351
6	GILD	Gilead Sciences, Inc.	31,176	$3,938,775
7	AMGN	Amgen Inc	10,471	$3,791,758
8	NVO	Novo Nordisk A S This page	38,789	$1,859,544

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,859,544	38,789	-9.1%	Shares	Sole	2026-07-29
2026-03-31	$1,567,461	42,652	+85.4%	Shares	Sole	2026-04-15
2025-12-31	$1,170,290	23,001	-31.1%	Shares	Sole	2026-01-13
2025-09-30	$1,853,310	33,399	-65.3%	Shares	Sole	2025-10-15
2025-06-30	$6,648,834	96,332	+216.3%	Shares	Sole	2025-07-15
2025-03-31	$2,114,795	30,455	-24.5%	Shares	Sole	2025-05-07
2024-12-31	$3,468,412	40,321	-11.8%	Shares	Sole	2025-02-05
2024-09-30	$5,441,618	45,701	-11.7%	Shares	Sole	2024-10-17
2024-06-30	$7,389,935	51,772	+73.1%	Shares	Sole	2024-08-06
2024-03-31	$3,839,801	29,905	+16.0%	Shares	Sole	2024-04-30
2023-12-31	$2,666,630	25,777	-12.5%	Shares	Sole	2024-02-05
2023-09-30	$2,678,910	29,458	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.